Search

Your search keyword '"Haluzik, Martin"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Haluzik, Martin" Remove constraint Author: "Haluzik, Martin" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
23 results on '"Haluzik, Martin"'

Search Results

1. Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group

3. Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure

5. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

8. Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group

9. Mitochondrially targeted tamoxifen alleviates markers of obesity and type 2 diabetes mellitus in mice

10. Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction.

11. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

12. Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

13. Specific gut bacterial and fungal microbiota pattern in the first half of pregnancy is linked to the development of gestational diabetes mellitus in the cohort including obese women

14. Decreased Epicardial CTRP3 mRNA Levels in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease Undergoing Elective Cardiac Surgery: A Possible Association with Coronary Atherosclerosis

15. 1415-P: Risk–Benefit Data from the Worldwide EndoBarrier (EB) Registry

16. 875-P: Different Effects of SGLT-2 Inhibitors on Subcutaneous and Epicardial Adipose Tissue Metabolome in Heart Failure Subjects

22. Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group

Catalog

Books, media, physical & digital resources